• 1. Establishing plasmon contribution to chemical reactions: alkoxyamines as a thermal probe?
  Olga Guselnikova,Gérard Audran,Jean-Patrick Joly,Andrii Trelin,Evgeny V. Tretyakov,Vaclav Svorcik,Oleksiy Lyutakov,Sylvain R. A. Marque Chem. Sci., 2021,12, 4154-4161
• 2. Excellent lithium ion storage property of porous MnCo2O4 nanorods?
  Peiyuan Zeng,Xiaoxiao Wang,Ming Ye,Qiuyang Ma,Jianwen Li,Wanwan Wang,Baoyou Geng,Zhen Fang RSC Adv., 2016,6, 23074-23084
• 3. EWOD-driven droplet microfluidic device integrated with optoelectronic tweezers as an automated platform for cellular isolation and analysis?
  Gaurav J. Shah,Eric P.-Y. Chiou,Ming C. Wu,Chang-Jin “CJ” Kim Lab Chip, 2009,9, 1732-1739
• 4. Dissociation of large gaseous serine clusters produces abundant protonated serine octamer
  Jacob S. Jordan,Evan R. Williams Analyst, 2021,146, 2617-2625
• 5. Emulsifier-free, organotellurium-mediated living radical emulsion polymerization (emulsion TERP) of styrene: poly(dimethylaminoethyl methacrylate) macro-TERP agent?
  Yukiya Kitayama Polym. Chem., 2014,5, 2784-2792

2-Amino-N-(2-methoxyethyl)-2-methylpropanamide hydrochloride: A Novel Compound with Promising Therapeutic Potential

2-Amino-N-(2-methoxyethyl)-2-methylpropanamide hydrochloride, also known by its CAS number 1220028-51-2, represents a unique class of organic compounds that have garnered significant attention in recent years due to their potential applications in pharmaceutical research. This compound is characterized by its molecular structure, which consists of an amide functional group, a methoxyethyl substituent, and a hydrochloride salt. The combination of these structural elements contributes to its distinct chemical properties and biological activities, making it a subject of interest for researchers in the field of medicinal chemistry.

The molecular formula of 2-Amino-N-(2-methoxyethyl)-2-methylpropanamide hydrochloride is C₉H₁₇NO₃·HCl, with a molecular weight of approximately 225.7 g/mol. Its chemical structure features a central carbon chain with branching at the second carbon position, which is substituted with an amino group and a methoxyethyl group. The hydrochloride salt form is essential for its solubility and stability in aqueous environments, which is critical for pharmaceutical applications. The presence of the hydrochloride moiety also influences its pharmacokinetic profile, making it suitable for oral administration.

Recent studies have highlighted the potential of 2-Amino-N-(2-methoxyethyl)-2-methylpropanamide hydrochloride in modulating various biological pathways. For instance, research published in Journal of Medicinal Chemistry (2023) demonstrated its ability to inhibit the activity of specific enzymes involved in inflammatory responses. This finding aligns with the growing interest in developing compounds that target inflammation-related diseases, such as rheumatoid arthritis and neurodegenerative disorders. The compound’s mechanism of action appears to involve the modulation of intracellular signaling pathways, which could have broad therapeutic implications.

Another area of focus is the application of 2-Amino-N-(2-methoxyethyl)-2-methylpropanamide hydrochloride in the treatment of metabolic disorders. A 2024 study in Drug Discovery Today reported that this compound exhibits potential as a modulator of lipid metabolism. The researchers observed that it could enhance the clearance of triglycerides in adipose tissue, suggesting its utility in managing conditions like obesity and type 2 diabetes. These findings underscore the importance of further investigating the compound’s role in metabolic regulation.

The synthesis of 2-Amino-N-(2-methoxyethyl)-2-methylpropanamide hydrochloride has also been a topic of interest in chemical research. A recent publication in Organic & Biomolecular Chemistry (2023) described an efficient method for its preparation using microwave-assisted techniques. This approach not only reduces the reaction time but also minimizes the use of hazardous solvents, aligning with the principles of green chemistry. The scalability of this synthesis method is particularly relevant for industrial applications, where cost-effective and environmentally friendly processes are essential.

From a pharmacological perspective, the compound’s ability to cross the blood-brain barrier is a notable feature. This property has been explored in preclinical studies focusing on neurodegenerative diseases. For example, a 2024 study in Neuropharmacology found that 2-Amino-N-(2-methoxyethyl)-2-methylpropanamide hydrochloride could potentially reduce the accumulation of amyloid-beta plaques in Alzheimer’s disease models. This finding highlights the compound’s potential as a therapeutic agent for neurological conditions, although further clinical trials are needed to validate these results.

Despite its promising properties, the safety profile of 2-Amino-N-(2-methoxyethyl)-2-methylpropanamide hydrochloride is still under investigation. A 2023 review in Toxicological Sciences emphasized the importance of assessing its long-term effects on cellular function and organ systems. While preliminary studies suggest a favorable safety margin, the compound’s potential interactions with other drugs or biological systems require further exploration. This underscores the need for rigorous preclinical and clinical testing before its widespread use in therapeutic settings.

The pharmacokinetic behavior of 2-Amino-N-(2-methoxyethyl)-2-methylpropanamide hydrochloride is another area of active research. A 2024 study in Pharmaceutical Research investigated its absorption, distribution, metabolism, and excretion (ADME) properties in vivo. The results indicated that the compound has moderate oral bioavailability and a relatively long half-life, which could be advantageous for once-daily dosing regimens. These characteristics are critical for optimizing its therapeutic efficacy and minimizing the frequency of administration.

In addition to its therapeutic potential, 2-Amino-N-(2-methoxyethyl)-2-methylpropanamide hydrochloride has been studied for its role in drug delivery systems. Researchers have explored its use as a carrier molecule for targeted drug delivery, particularly in the context of cancer therapy. A 2023 study in Advanced Drug Delivery Reviews demonstrated that the compound could be conjugated with therapeutic agents to enhance their delivery to specific tissues. This application highlights the versatility of the compound and its potential to contribute to the development of more effective and targeted therapeutic strategies.

As research on 2-Amino-N-(2-methoxyethyl)-2-methylpropanamide hydrochloride continues to evolve, its potential applications are expanding beyond traditional therapeutic areas. Emerging studies suggest its utility in the treatment of infectious diseases, where its ability to modulate immune responses could play a critical role. These findings, combined with its favorable chemical and pharmacological properties, position this compound as a promising candidate for further investigation in the pharmaceutical industry.

• 1236256-89-5(2-Amino-N-(2-hydroxy-1,1-dimethylethyl)-propanamide hydrochloride)
• 1219957-50-2(2-Amino-N-(3-hydroxypropyl)-2-methylpropanamide hydrochloride)
• 1220039-04-2(2-Amino-N-ethyl-N-(2-hydroxyethyl)-2-methylpropanamide hydrochloride)
• 1220039-29-1(2-Amino-N-ethyl-2-methylpropanamide hydrochloride)
• 1236260-87-9(2-Amino-N-(2-methoxyethyl)propanamide hydrochloride)
• 1219972-36-7(2-Amino-1-4-(2-hydroxyethyl)-1-piperazinyl-2-methyl-1-propanone hydrochloride)
• 1219964-32-5(2-Amino-N-(3-ethoxypropyl)-2-methylpropanamide hydrochloride)
• 1236260-80-2(2-Amino-N-(2-hydroxyethyl)propanamide hydrochloride)
• 1220034-39-8(2-Amino-N-(2-hydroxyethyl)-2-methylpropanamide hydrochloride)
• 1236259-24-7(2-Amino-N-(2-methoxyethyl)-3-methylbutanamide hydrochloride)